NCT03484013View on ClinicalTrials.gov

Totally Percutaneous Approach to Endovascular Treatment of Aortic Aneurysms (PEVAR-PRO)

CompletedOBSERVATIONAL
Enrollment

320

Participants

Timeline

Start Date

January 9, 2019

Primary Completion Date

March 31, 2020

Study Completion Date

March 31, 2020

Conditions
AneurysmAneurysm AbdominalAneurysm ThoracicAneurysm, Thoracoabdominal Aortic
Trial Locations (1)

20132

San Raffaele Hospital, Milan

All Listed Sponsors
lead

IRCCS San Raffaele

OTHER

NCT03484013 - Totally Percutaneous Approach to Endovascular Treatment of Aortic Aneurysms (PEVAR-PRO) | Biotech Hunter | Biotech Hunter